Page last updated: 2024-08-23

phosphotyrosine and Idiopathic Parkinson Disease

phosphotyrosine has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brahmachari, S; Dawson, TM; Dawson, VL; Ge, P; Karuppagounder, SS; Kim, D; Ko, HS; Kumar, M; Lee, SH; Lee, Y; Mao, X; Pletnikova, O; Shin, JH; Troncoso, JC	1

Other Studies

1 other study(ies) available for phosphotyrosine and Idiopathic Parkinson Disease

Article	Year
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration. The Journal of clinical investigation, 2016, 08-01, Volume: 126, Issue:8 Topics: Aged; alpha-Synuclein; Animals; Brain; Disease Models, Animal; Female; Gene Deletion; HEK293 Cells; Humans; Lewy Bodies; Male; Mice; Mice, Transgenic; Mutation; Neurites; Neurodegenerative Diseases; Neuroprotection; Parkinson Disease; Phosphorylation; Phosphotyrosine; Proto-Oncogene Proteins c-abl	2016

Article

Year

Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.

The Journal of clinical investigation, 2016, 08-01, Volume: 126, Issue:8

Topics: Aged; alpha-Synuclein; Animals; Brain; Disease Models, Animal; Female; Gene Deletion; HEK293 Cells; Humans; Lewy Bodies; Male; Mice; Mice, Transgenic; Mutation; Neurites; Neurodegenerative Diseases; Neuroprotection; Parkinson Disease; Phosphorylation; Phosphotyrosine; Proto-Oncogene Proteins c-abl

2016